FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3133771337> ?p ?o ?g. }

• W3133771337 endingPage "525" @default.
• W3133771337 startingPage "516" @default.
• W3133771337 abstract "Aim: To identify drug-related death trends associated with synthetic cannabinoid receptor agonists (SCRAs) reported to the National Programme on Substance Abuse Deaths (NPSAD) from England. Design: Case reports from NPSAD (England) where a SCRA was detected in post-mortem tissue(s) and/or implicated in the death were extracted, analyzed, and compared against non-SCRA-related deaths that occurred over the same time period (2012-2019). Findings: One hundred sixty-five death SCRA-related reports were extracted, with 18 different SCRAs detected. Following the first death in 2012, a subsequent sharp increase in reporting is evident. Acute SCRA use was the underlying cause of death in the majority of cases (75.8%) with cardiorespiratory complications the most frequently cited underlying physiological cause (13.4%). SCRA users were predominantly found dead (68.6%), with a large proportion of those witnessed becoming unresponsive described as suddenly collapsing (81.6%). Psychoactive polydrug use was detected in 90.3% of cases, with alcohol the most commonly co-detected (50.3%), followed by opioids (42.2%), benzodiazepines/Z-drugs (32.1%), stimulants (32.1%, [28.5% cocaine]), and cannabis (24.8%). Compared to all non-SCRA-related NPSAD deaths occurring over the same time period, SCRA-related decedents were more predominantly male (90.3% vs. 72.0%; p<0.01), and lived in more deprived areas (p<0.01). While a comparatively significant proportion of decedents were homeless (19.4% vs. 4.1%), living in a hostel (13.3% vs. 2.3%) or in prison (4.9% vs. 0.2%) at time of death (all p<0.01), the greatest majority of SCRA-related decedents were living in private residential accommodations (57.6%). Conclusions: This is the largest dataset regarding SCRA-related mortalities reported to date. Reporting of SCRA-related deaths in England have increased considerably, with polydrug use a specific concern. Lack of effective deterrents to SCRA use under current UK legislation, compounded by limited knowledge regarding the physiological impacts of SCRA consumption and their interaction with other co-administered substances are contributory factors to the occurrence of SCRA-related mortalities in an increasingly deprived demographic." @default.
• W3133771337 created "2021-03-15" @default.
• W3133771337 creator A5011452697 @default.
• W3133771337 creator A5029099455 @default.
• W3133771337 creator A5031971681 @default.
• W3133771337 creator A5032538605 @default.
• W3133771337 creator A5047884739 @default.
• W3133771337 creator A5053962983 @default.
• W3133771337 date "2022-08-01" @default.
• W3133771337 modified "2023-10-13" @default.
• W3133771337 title "Synthetic Cannabinoid-Related Deaths in England, 2012–2019" @default.
• W3133771337 cites W1517359192 @default.
• W3133771337 cites W1782135008 @default.
• W3133771337 cites W1920718980 @default.
• W3133771337 cites W1968029665 @default.
• W3133771337 cites W1991823434 @default.
• W3133771337 cites W2007485514 @default.
• W3133771337 cites W2009785311 @default.
• W3133771337 cites W2032907021 @default.
• W3133771337 cites W2064958196 @default.
• W3133771337 cites W2074114778 @default.
• W3133771337 cites W2092069105 @default.
• W3133771337 cites W2108974301 @default.
• W3133771337 cites W2135406650 @default.
• W3133771337 cites W2153539777 @default.
• W3133771337 cites W2223658309 @default.
• W3133771337 cites W2253851548 @default.
• W3133771337 cites W2341441271 @default.
• W3133771337 cites W2414702405 @default.
• W3133771337 cites W2463316012 @default.
• W3133771337 cites W2516143102 @default.
• W3133771337 cites W2520865586 @default.
• W3133771337 cites W2554232242 @default.
• W3133771337 cites W2565242041 @default.
• W3133771337 cites W2598708969 @default.
• W3133771337 cites W2611650218 @default.
• W3133771337 cites W2658307868 @default.
• W3133771337 cites W2741227075 @default.
• W3133771337 cites W2747453246 @default.
• W3133771337 cites W2769499227 @default.
• W3133771337 cites W278068762 @default.
• W3133771337 cites W2793537300 @default.
• W3133771337 cites W2793738430 @default.
• W3133771337 cites W2885531674 @default.
• W3133771337 cites W2888899005 @default.
• W3133771337 cites W2900920500 @default.
• W3133771337 cites W2901864956 @default.
• W3133771337 cites W2906294485 @default.
• W3133771337 cites W2909923904 @default.
• W3133771337 cites W2911608221 @default.
• W3133771337 cites W2916161759 @default.
• W3133771337 cites W2916694194 @default.
• W3133771337 cites W2944565162 @default.
• W3133771337 cites W2965679873 @default.
• W3133771337 cites W2968067900 @default.
• W3133771337 cites W2972158209 @default.
• W3133771337 cites W2978668415 @default.
• W3133771337 cites W2981844663 @default.
• W3133771337 cites W2982311497 @default.
• W3133771337 cites W2988233660 @default.
• W3133771337 cites W2997802563 @default.
• W3133771337 cites W3000660644 @default.
• W3133771337 cites W3003862606 @default.
• W3133771337 cites W3010031220 @default.
• W3133771337 cites W3010279514 @default.
• W3133771337 cites W3011350093 @default.
• W3133771337 cites W3013129565 @default.
• W3133771337 cites W3028648868 @default.
• W3133771337 cites W3044048769 @default.
• W3133771337 doi "https://doi.org/10.1089/can.2020.0161" @default.
• W3133771337 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33998886" @default.
• W3133771337 hasPublicationYear "2022" @default.
• W3133771337 type Work @default.
• W3133771337 sameAs 3133771337 @default.
• W3133771337 citedByCount "13" @default.
• W3133771337 countsByYear W31337713372021 @default.
• W3133771337 countsByYear W31337713372022 @default.
• W3133771337 countsByYear W31337713372023 @default.
• W3133771337 crossrefType "journal-article" @default.
• W3133771337 hasAuthorship W3133771337A5011452697 @default.
• W3133771337 hasAuthorship W3133771337A5029099455 @default.
• W3133771337 hasAuthorship W3133771337A5031971681 @default.
• W3133771337 hasAuthorship W3133771337A5032538605 @default.
• W3133771337 hasAuthorship W3133771337A5047884739 @default.
• W3133771337 hasAuthorship W3133771337A5053962983 @default.
• W3133771337 hasBestOaLocation W31337713372 @default.
• W3133771337 hasConcept C118552586 @default.
• W3133771337 hasConcept C126322002 @default.
• W3133771337 hasConcept C144024400 @default.
• W3133771337 hasConcept C149923435 @default.
• W3133771337 hasConcept C2777056318 @default.
• W3133771337 hasConcept C2779134260 @default.
• W3133771337 hasConcept C29374701 @default.
• W3133771337 hasConcept C71924100 @default.
• W3133771337 hasConceptScore W3133771337C118552586 @default.
• W3133771337 hasConceptScore W3133771337C126322002 @default.
• W3133771337 hasConceptScore W3133771337C144024400 @default.
• W3133771337 hasConceptScore W3133771337C149923435 @default.

• next